glp 1 agonist euglycemic dka SGLT-2 Inhibitors and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Possible mechanism of euglycemic DKA

1,2,4,5 At therapeutic doses, the dihydropyridines predominantly affect vascular smooth muscle cells and show little effect on the myocardium, making this class of CCAs particularly attractive in treating hypertension

Pearlstein et al., 2002

Revolutionary NNMT Inhibition Mechanism 5-Amino-1MQ functions as a potent selective inhibitor of nicotinamide N-methyltransferase with IC = 1M, preventing the enzyme from converting nicotinamide to 1-methylnicotinamide

S2CID 27279712

injections varied depending on the test animal, reaching levels of approximately 1419% and 4551% in rats and beagle dogs, respectively

RSC Adv 13(24):1651216528